Genus (LON:GNS)‘s stock had its “hold” rating reissued by research analysts at Liberum Capital in a research report issued to clients and investors on Friday.
Other equities research analysts also recently issued reports about the company. Peel Hunt reiterated a “hold” rating on shares of Genus in a research report on Thursday. Kepler Capital Markets upgraded Genus to a “buy” rating and boosted their target price for the stock from GBX 2,475 ($32.34) to GBX 2,630 ($34.37) in a research report on Thursday.
LON GNS opened at GBX 2,386 ($31.18) on Friday. Genus has a twelve month low of GBX 1,652 ($21.59) and a twelve month high of GBX 2,597 ($33.93).
In related news, insider Karim Bitar sold 5,920 shares of the business’s stock in a transaction dated Monday, September 17th. The stock was sold at an average price of GBX 2,538 ($33.16), for a total value of £150,249.60 ($196,327.71).
Genus Company Profile
Genus plc operates as an animal genetics company in North America, Latin America, rest of Europe, the Middle East, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Research and Development. It sells sows, boars, and semen to breed pigs with various characteristics for pork production under the PIC brand.
Featured Article: Exchange-Traded Funds (ETFs)
Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.